Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma
Joint Authors
Graceffa, Dario
Pace, Andrea
Solivetti, Francesco M.
Maiani, E.
Bonifati, C.
Elia, F.
De Mutiis, C.
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-11-29
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF).
The drug, alone or in combination with other anticancer agents, has been shown to be effective against several types of neoplasms.
We report a case of a woman with a history of severe psoriasis who developed psoriatic arthritis during a course of bevacizumab, which was administered for a malignant glioma.
American Psychological Association (APA)
Graceffa, Dario& Maiani, E.& Pace, Andrea& Solivetti, Francesco M.& Elia, F.& De Mutiis, C.…[et al.]. 2012. Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma. Case Reports in Rheumatology،Vol. 2012, no. 2012, pp.1-3.
https://search.emarefa.net/detail/BIM-454666
Modern Language Association (MLA)
Graceffa, Dario…[et al.]. Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma. Case Reports in Rheumatology No. 2012 (2012), pp.1-3.
https://search.emarefa.net/detail/BIM-454666
American Medical Association (AMA)
Graceffa, Dario& Maiani, E.& Pace, Andrea& Solivetti, Francesco M.& Elia, F.& De Mutiis, C.…[et al.]. Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma. Case Reports in Rheumatology. 2012. Vol. 2012, no. 2012, pp.1-3.
https://search.emarefa.net/detail/BIM-454666
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-454666
